| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Marco Falcone | Q37831273 |
| Marin H Kollef | Q76082664 | ||
| Mario Venditti | Q88922328 | ||
| P2093 | author name string | Yuichiro Shindo | |
| P433 | issue | 8 | |
| P921 | main subject | pneumonia | Q12192 |
| diagnosis | Q16644043 | ||
| P304 | page(s) | e545-50 | |
| P577 | publication date | 2011-05-26 | |
| P1433 | published in | International Journal of Infectious Diseases | Q15262334 |
| P1476 | title | Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia | |
| P478 | volume | 15 |
| Q90226056 | A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia |
| Q39562358 | Cardiovascular Complications and Short-term Mortality Risk in Community-Acquired Pneumonia |
| Q37073992 | Chitinase 3-Like 1 (Chil1) Regulates Survival and Macrophage-Mediated Interleukin-1β and Tumor Necrosis Factor Alpha during Pseudomonas aeruginosa Pneumonia |
| Q35111689 | Classification of healthcare-associated infection: a systematic review 10 years after the first proposal |
| Q41560626 | Clinical and microbiological features of patients admitted to the intensive care unit with nursing and healthcare-associated pneumonia |
| Q84356030 | Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study |
| Q35086947 | Clinical implications for patients treated inappropriately for community-acquired pneumonia in the emergency department |
| Q49980170 | Comparison of viral infection in healthcare-associated pneumonia (HCAP) and community-acquired pneumonia (CAP). |
| Q36700064 | Expanded CURB-65: a new score system predicts severity of community-acquired pneumonia with superior efficiency |
| Q36281234 | Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations |
| Q38346319 | Healthcare-associated Pneumonia and Aspiration Pneumonia |
| Q36531884 | Healthcare-associated Pneumonia: Clinical Features and Retrospective Analysis Over 10 Years |
| Q36566789 | Hospitalization for Pneumonia is Associated With Decreased 1-Year Survival in Patients With Type 2 Diabetes: Results From a Prospective Cohort Study |
| Q38215670 | Identification and management of invasive mycoses in internal medicine: a road-map for physicians |
| Q35362847 | Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia |
| Q35088200 | Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin. |
| Q38017909 | Pneumonia in frail older patients: an up to date |
| Q92354578 | Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia |
| Q38646554 | Regional differences in antibiotic-resistant pathogens in patients with pneumonia: Implications for clinicians |
| Q42608997 | Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia |
| Q38160635 | The changing microbiologic epidemiology of community-acquired pneumonia |
| Q34711734 | The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response |
Search more.